| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Barry J Maron, Susan A Casey, Raymond H Chan, Ross F Garberich, Ethan J Rowin, Martin S Maro. Independent Assessment of the European Society of Cardiology Sudden Death Risk Model for Hypertrophic Cardiomyopathy. The American journal of cardiology. vol 116. issue 5. 2015-11-10. PMID:26183790. |
risk stratification for sudden death (sd) is an essential component of hypertrophic cardiomyopathy (hc) management, given the proven effectiveness of implantable cardioverter-defibrillators (icd) for preventing sd. |
2015-11-10 |
2023-08-13 |
Not clear |
| Lukas Ruzek, Tomas Konecny, Filip Soucek, Dana Konecny, Lukas Mach, Steve R Ommen, Stephen L Kopecky, Rick A Nishimur. Phosphodiesterase 5 Inhibitor Use in Men With Hypertrophic Cardiomyopathy. The American journal of cardiology. vol 116. issue 4. 2015-10-19. PMID:26141201. |
the prevalence of sexual dysfunction (sd) in men with hypertrophic cardiomyopathy (hc) remains unknown, yet its clinical relevance may be high given that its treatment-phosphodiesterase 5 inhibitors (pde5i)-can increase the left ventricular outflow tract pressure gradient. |
2015-10-19 |
2023-08-13 |
Not clear |
| Pedro W Machado de Almeida, Marcos Barrouin Melo, Ricardo de Freitas Lima, Mariana Gavioli, Nivia M Santiago, Leonardo Greco, Itamar C G Jesus, Eduardo Nocchi, Amanda Parreira, Marcia N M Alves, Luciana Mitraud, Rodrigo Ribeiro Resende, Maria Jos\\xc3\\xa9 Campagnole-Santos, Robson Augusto Souza Dos Santos, Silvia Guatimosi. Beneficial effects of angiotensin-(1-7) against deoxycorticosterone acetate-induced diastolic dysfunction occur independently of changes in blood pressure. Hypertension (Dallas, Tex. : 1979). vol 66. issue 2. 2015-09-30. PMID:26077567. |
after treatment, sd rats became hypertensive and developed ventricular hypertrophy. |
2015-09-30 |
2023-08-13 |
rat |
| Raymond H Chan, Barry J Maron, Iacopo Olivotto, Gabriele E Assenza, Tammy S Haas, John R Lesser, Christiane Gruner, Andrew M Crean, Harry Rakowski, Ethan Rowin, James Udelson, Massimo Lombardi, Benedetta Tomberli, Paolo Spirito, Francesco Formisano, Martina P Marra, Elena Biagini, Camillo Autore, Warren J Manning, Evan Appelbaum, William C Roberts, Cristina Basso, Martin S Maro. Significance of Late Gadolinium Enhancement at Right Ventricular Attachment to Ventricular Septum in Patients With Hypertrophic Cardiomyopathy. The American journal of cardiology. vol 116. issue 3. 2015-09-21. PMID:26026863. |
cardiovascular magnetic resonance (cmr) with extensive late gadolinium enhancement (lge) is a novel marker for increased risk for sudden death (sd) in patients with hypertrophic cardiomyopathy (hc). |
2015-09-21 |
2023-08-13 |
Not clear |
| Jun-Ichi Akagi, Takeshi Toyoda, Young-Man Cho, Yasuko Mizuta, Takehiko Nohmi, Akiyoshi Nishikawa, Kumiko Ogaw. Validation study of the combined repeated-dose toxicity and genotoxicity assay using gpt delta rats. Cancer science. vol 106. issue 5. 2015-08-25. PMID:25683344. |
gpt delta rats treated with dehp showed similar increases in liver and kidney weights, serum albumin, albumin/globulin ratios, and incidence of diffuse hepatocyte hypertrophy compared to wt f344 and sprague-dawley (sd) rats. |
2015-08-25 |
2023-08-13 |
rat |
| Pietro Francia, Daria Santini, Beatrice Musumeci, Lorenzo Semprini, Carmen Adduci, Erika Pagannone, Giulia Proietti, Massimo Volpe, Camillo Autor. Clinical impact of nonsustained ventricular tachycardia recorded by the implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy. Journal of cardiovascular electrophysiology. vol 25. issue 11. 2015-07-20. PMID:25066044. |
nonsustained ventricular tachycardia (nsvt) is a risk factor for sudden death (sd) in hypertrophic cardiomyopathy (hcm). |
2015-07-20 |
2023-08-13 |
Not clear |
| Hao-Chuan Liu, Amandine Perrin, Ting-Rong Hsu, Chia-Feng Yang, Hsiang-Yu Lin, Wen-Chung Yu, Dau-Ming Ni. Age at First Cardiac Symptoms in Fabry Disease: Association with a Chinese Hotspot Fabry Mutation (IVS4+919G>A), Classical Fabry Mutations, and Sex in a Taiwanese Population from the Fabry Outcome Survey (FOS). JIMD reports. vol 22. 2015-07-01. PMID:25762495. |
of 55 (93%) patients with reported left ventricular hypertrophy (lvh), mean [sd] age (years) at first symptom was lower in classical fabry males (30.0 [15.1]; n\xe2\x80\x89=\xe2\x80\x894) than classical fabry females (49.6 [8.9]; n\xe2\x80\x89=\xe2\x80\x8911; p\xe2\x80\x89<\xe2\x80\x890.05), but not in ivs4 females (57.4 [13.7]; n\xe2\x80\x89=\xe2\x80\x8910) compared with ivs4 males (55.9 [11.3]; n\xe2\x80\x89=\xe2\x80\x8930). |
2015-07-01 |
2023-08-13 |
Not clear |
| Georgios K Efthimiadis, Thomas Zegkos, Soultana Meditskou, Stavros Hadjimiltiade. Perspectives on sudden death prevention in hypertrophic cardiomyopathy. Cardiology in review. vol 22. issue 5. 2015-04-13. PMID:25093740. |
sudden death (sd) is the most dramatic event in hypertrophic cardiomyopathy (hcm), often representing the first clinical manifestation of the disease, and the first concern of the clinicians who take care of such patients. |
2015-04-13 |
2023-08-13 |
Not clear |
| Inge Elly Kiemle Trindade, Priscila Capelato Prado Conegliam, Sergio Henrique Kiemle Trindade, Norimar Hernandes Dias, Ana Claudia Martins Sampaio-Teixeir. Internal nasal dimensions of adults with nasal obstruction. Brazilian journal of otorhinolaryngology. vol 79. issue 5. 2014-02-07. PMID:24141671. |
nasal septum deviation (sd) and turbinate hypertrophy (th) increase the resistance to respiratory airflow and may impair nasal patency. |
2014-02-07 |
2023-08-12 |
Not clear |
| E Braunlin, H Rosenfeld, C Kampmann, J Johnson, M Beck, R Giugliani, N Guffon, D Ketteridge, C M S\\xc3\\xa1 Miranda, M Scarpa, I V Schwartz, E Le\\xc3\\xa3o Teles, J E Wraith, P Barrios, E Dias da Silva, G Kurio, M Richardson, G Gildengorin, J J Hopwood, M Imperiale, A Schatz, C Decker, P Harmat. Enzyme replacement therapy for mucopolysaccharidosis VI: long-term cardiac effects of galsulfase (Naglazyme\\xc2\\xae) therapy. Journal of inherited metabolic disease. vol 36. issue 2. 2014-01-14. PMID:22669363. |
left ventricular hypertrophy, with averaged z-scores ranging from 1.6-1.9 sd greater than normal, was present for ages both <12 and \xe2\x89\xa512\xc2\xa0years. |
2014-01-14 |
2023-08-12 |
human |
| Desy Salvadego, Rossana Domenis, Stefano Lazzer, Simone Porcelli, J\\xc3\\xb6rn Rittweger, Giovanna Rizzo, Irene Mavelli, Bostjan Simunic, Rado Pisot, Bruno Grass. Skeletal muscle oxidative function in vivo and ex vivo in athletes with marked hypertrophy from resistance training. Journal of applied physiology (Bethesda, Md. : 1985). vol 114. issue 11. 2014-01-06. PMID:23519233. |
oxidative function during exercise was evaluated in 11 young athletes with marked skeletal muscle hypertrophy induced by long-term resistance training (rta; body mass 102.6 \xc2\xb1 7.3 kg, mean \xc2\xb1 sd) and 11 controls (ctrl; body mass 77.8 \xc2\xb1 6.0 kg). |
2014-01-06 |
2023-08-12 |
Not clear |
| Junfang Zhang, Cong Wei, Hongtao Wang, Siwen Tang, Zhenhua Jia, Lei Wang, Dengfeng Xu, Yiling W. Protective effect of qiliqiangxin capsule on energy metabolism and myocardial mitochondria in pressure overload heart failure rats. Evidence-based complementary and alternative medicine : eCAM. vol 2013. 2013-09-30. PMID:24078824. |
sd rats received ascending aorta constriction (tac) to establish a model of myocardial hypertrophy. |
2013-09-30 |
2023-08-12 |
rat |
| Izuru Miyawaki, Akitoshi Tamura, Izumi Matsumoto, Hiroshi Inada, Takeshi Kunimatsu, Juki Kimura, Hitoshi Funabash. The effects of clobazam treatment in rats on the expression of genes and proteins encoding glucronosyltransferase 1A/2B (UGT1A/2B) and multidrug resistance-associated protein-2 (MRP2), and development of thyroid follicular cell hypertrophy. Toxicology and applied pharmacology. vol 265. issue 3. 2013-04-24. PMID:22982618. |
clobazam (clb) is known to increase hepatobiliary thyroxine (t4) clearance in sprague-dawley (sd) rats, which results in hypothyroidism followed by thyroid follicular cell hypertrophy. |
2013-04-24 |
2023-08-12 |
rat |
| Tomo Suzuki, Shoichi Kado, Minoru Ando, Yuriko Nagata, Shin Iwata, Toshihide Kobayashi, Kazumi Uchid. Spontaneous Cardiac Hypertrophy in a Crl:CD(SD) Rat. Journal of toxicologic pathology. vol 22. issue 1. 2012-08-23. PMID:22271980. |
spontaneous cardiac hypertrophy in a crl:cd(sd) rat. |
2012-08-23 |
2023-08-12 |
rat |
| Tomo Suzuki, Shoichi Kado, Minoru Ando, Yuriko Nagata, Shin Iwata, Toshihide Kobayashi, Kazumi Uchid. Spontaneous Cardiac Hypertrophy in a Crl:CD(SD) Rat. Journal of toxicologic pathology. vol 22. issue 1. 2012-08-23. PMID:22271980. |
cardiac hypertrophy was observed in a 9-week-old crl:cd(sd) rat that died unexpectedly. |
2012-08-23 |
2023-08-12 |
rat |
| Akintunde O Akinkuolie, Megan Aleardi, Ajibade O Ashaye, J Michael Gaziano, Luc Djouss\\xc3\\xa. Height and risk of heart failure in the Physicians' Health Study. The American journal of cardiology. vol 109. issue 7. 2012-05-18. PMID:22221952. |
the exclusion of those with prevalent atrial fibrillation, left ventricular hypertrophy, valvular heart disease, and a history of coronary artery bypass grafting yielded similar results (hr per sd 0.88, 95% ci 0.83 to 0.94). |
2012-05-18 |
2023-08-12 |
human |
| Yi Yang, Rita Ciurlionis, Kenneth Kowalkowski, Kennan C Marsh, William M Bracken, Eric A G Blomm. N-vinylpyrrolidone dimer, a novel formulation excipient, causes hepatic and thyroid hypertrophy through the induction of hepatic microsomal enzymes in rats. Toxicology letters. vol 208. issue 1. 2012-01-11. PMID:22037397. |
in a previous 4-week toxicity study, vpd induced dose-dependent hepatocellular and thyroid gland hypertrophy in sprague-dawley (sd) rats. |
2012-01-11 |
2023-08-12 |
rat |
| Yi Yang, Rita Ciurlionis, Kenneth Kowalkowski, Kennan C Marsh, William M Bracken, Eric A G Blomm. N-vinylpyrrolidone dimer, a novel formulation excipient, causes hepatic and thyroid hypertrophy through the induction of hepatic microsomal enzymes in rats. Toxicology letters. vol 208. issue 1. 2012-01-11. PMID:22037397. |
collectively, these data indicate that vpd acts as an inducer of hepatic dmes in sd rats and that this likely leads to enhanced peripheral metabolism of t3/t4, resulting in a feedback response characterized by increased serum tsh levels, and thyroid gland hypertrophy and hyperplasia. |
2012-01-11 |
2023-08-12 |
rat |
| Jing Dong, Xiaoping Chen, Yanling So, Hongbo Xin, Wei Jiang, Lingyun Jian. [Intermedin (IMD) gene expression in hypertrophic cardiac myocyte of renal vascular hypertension rats and the intervention of Valsartan, Amlodipine and Enalapril in the expression]. Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi. vol 26. issue 5. 2011-12-15. PMID:19947495. |
at 4 weeks after successful modeling, 60 sd male rats were randomly divided into 5 groups, namely the hypertrophy group, the 3 drug-treatment groups, and the sham-operation group as control. |
2011-12-15 |
2023-08-12 |
rat |
| Pawel Petkow Dimitrow, Lidia Chojnowska, Tomasz Rudzinski, Walerian Piotrowski, Lidia Zi\\xc3\\xb3lkowska, Andrzej Wojtarowicz, Anna Wycisk, Alicja Dabrowska-Kugacka, Ewa Nowalany-Kozielska, Bozena Sobkowicz, Wojciech Wr\\xc3\\xb3bel, Janina Aleszewicz-Baranowska, Andrzej Rynkiewicz, Krystyna Loboz-Grudzien, Michal Marchel, Andrzej Wysokinsk. Sudden death in hypertrophic cardiomyopathy: old risk factors re-assessed in a new model of maximalized follow-up. European heart journal. vol 31. issue 24. 2011-12-07. PMID:20843960. |
in hypertrophic cardiomyopathy (hcm), the following five risk factors have a major role in the primary prevention of sudden death (sd): family history of sd (fhsd), syncope, massive wall thickness (mwth) >30 mm, non-sustained ventricular tachycardia (nsvt) in holter monitoring of electrocardiography, and abnormal blood pressure response to exercise (abpre). |
2011-12-07 |
2023-08-12 |
Not clear |